FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): TAK-788
Approved:
Kinase Class: RY
Inhibitor Type: VI
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s):
Disease(s): non-small-cell lung carcinoma

Mobocertinib US FDA Label

Compound: propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate
Description: NA

International Nonproprietary Name: Mobocertinib [INN] (Source: PubChem)

KEGG Drug ID: D12001 (Source: PubChem)

USFDA Precision ID: UNII-39HBQ4A67L (Source: PubChem)

US Adopted Name: Mobocertinib [USAN] (Source: PubChem)

Sources: PubChem (4)